KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:ITEK
Delisted

Inotek Pharmaceuticals Corporation Fund Signals

$3.04
+0 (+0%)
At Close: Jan 22, 2018

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 3.450 14 days ( -16.48 % )
Last Price $3.04 0 %
High/ Low $3.04 - $3.04 0%
Chg 7 Days N/A $3.04 $3.04
Chg 30 Days 10.95 % $2.74 $3.04
Chg 12 mos 84.24 % $1.65 $3.04
Trend - 3 mos 21.42 % Width: 32.22 %
Trend - 12 mos 43.47 % Width: 141.95 %
Pred. range - 3 mos $3.04 - $4.03 0.132 % - 32.40 %
Pred. range - 12 mos $1.97 - $4.77 -35.20 % - 56.83 %
Short MA avg 3 mos Buy Jan 11, 2018 - 8 days
Long MA avg 3 mos Buy Dec 18, 2017 - 24 days
Short/Long MA avg 3 mos Buy Dec 21, 2017 - 21 days
Short MA avg 12 mos Buy Jan 19, 2018 - 2 days
Long MA avg 12 mos Buy Sep 19, 2017 - 87 days
Short/Long MA avg 12 mos Buy Sep 26, 2017 - 82 days
Pivot Short Buy Jan 04, 2018 - 13 days
Bollinger Sell Nov 30, -1 - N/A days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Inotek Pharmaceuticals Corporation

Inotek Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for glaucoma and other diseases of the eye in the United States. The company’s lead product candidate includes Trabodenoson, a monotherapy that is in Phase III clinical trials for lowering IOP by restoring the eye’s natural pressure control mechanism. It is also developing Trabodenoson plus La... ITEK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT